Click to Share
 

Vaccine Research Press Releases

Exclusive News
Topics Locations Industries Dates

By BPS Bioscience, Inc.
BPS Bioscience, Inc. (“BPS”) announces Ebola virus glycoproteins for drug discovery research use.
By Biotech Support Group LLC
Cholesterol removal from serum samples using Cleanascite™ for immunogenicity and safety endpoint analysis of pneumococcal pneumolysin derivative PlyD1 in a single-antigen protein vaccine.

Page updated every 10 minutes


Like PRLog?
9K2K1K
Click to Share